AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9762741
Drug: saline medial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saline medial branch injections
Trial: 7909099
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) at 0.4 g/kg body weight
Trial: 2439559
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (1,640 patients randomized to placebo therapy)
Trial: 29718329
Drug: Ridinilazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ridinilazole (200 mg twice daily)
Trial: 29718329
Drug: Vancomycin (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (125 mg four times daily)
Trial: 23548219
Drug: Intraumbilical vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraumbilical vein oxytocin injection (10 IU, 1 mL)
Trial: 21139155
Drug: Injection with
RxNorm normalized name: Temsirolimus 25mg/1mL Solution for injection with Diluent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection with laboratory-prepared, amplified collagen-producing cells derived from dermal fibroblasts and suspended in autologous plasma
Trial: 12699514
Drug: Heat and
RxNorm normalized name: TRACH,FILTER HEAT AND MOISTURE EXCHANGER MEDLINE #DYNJAAHME5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat and moisture exchangers (HMEs) with fresh gas flows of 1.0, 3.0, or 6.0 l min‐1
Trial: 12699514
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without HMEs with fresh gas flows of 1.0, 3.0, or 6.0 l min‐1
Trial: 10967613
Drug: Oral iodised
RxNorm normalized name: calcium iodized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iodised oil (1 ml Lipiodol Ultrafluide, 490 mg I)
Trial: 29813111
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (IVT) within 4.5 hours after NA-CRAO
Trial: 29813111
Drug: Conservative standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative standard treatment (CST) from the EAGLE trial
Trial: 21246840
Drug: Blank group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blank group (no therapy applied)
Trial: 15196285
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone propionate (FP) 200 microg once daily
Trial: 15196285
Drug: Oral loratadine
RxNorm normalized name: loratadine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral loratadine (LOR) 10 mg once daily
Trial: 3498877
Drug: Doxycycline (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (one dose a day)
Trial: 3498877
Drug: Co-trimoxazole (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (two doses a day)
Trial: 3498877
Drug: Amoxycillin (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (three doses a day)
Trial: 3498877
Drug: Co-trimoxazole (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (two doses a day) with written instruction sheet and advice
Trial: 28934800
Drug: Intraarticular corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular corticosteroid injection (ICI)
Trial: 19491910
Drug: Rituximab, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab, a B‐cell‐depleting anti‐CD20 monoclonal antibody
Trial: 11380528
Drug: Exogenous melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exogenous melatonin (1 mg)
Trial: 11380528
Drug: 1-year oral
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 1-year oral melatonin treatment
Trial: 8250309
Drug: Continuous spinal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous spinal anesthesia (CSA) with 2.5-5 mg of plain bupivacaine 0.5%
Trial: 8250309
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anesthesia (SS) with 20 mg of plain bupivacaine 0.5%
Trial: 8250309
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anesthesia (SS)
Trial: 24934544
Drug: 1.7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 g DHA (22:6) and 0.6 g EPA (20:5) for 6 months
Trial: 22425127
Drug: Dutasteride (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (0.5 mg) and/or Tamsulosin (0.4 mg)
Trial: 16521850
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g L-Carnitine L-tartrate (LCLT) daily for 4 weeks
Trial: 16521850
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g placebo (P) daily for 4 weeks
Trial: 16521850
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g L-Carnitine L-tartrate (LCLT)
Trial: 9733448
Drug: Fludarabine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine 20 mg/m2 body surface area per day for 3 consecutive days
Trial: 9733448
Drug: Fludarabine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine 30 mg/m2 body surface area per day for 3 consecutive days
Trial: 8018458
Drug: Famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 20 mg four times daily
Trial: 4318020
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate (800 mg)
Trial: 4318020
Drug: Dichloral phenazone
RxNorm normalized name: phenazocine
DrugBank: Phenazocine (DB13606)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloral phenazone (1,300 mg)
Trial: 4318020
Drug: Mandrax (methaqualone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandrax (methaqualone 250 mg and diphenhydramine 25 mg)
Trial: 22486193
Drug: 0.2% alcohol-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% alcohol-free chlorhexidine mouthwash applied twice a day for 30 days
Trial: 11332356
Drug: Antioxidants (vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants (vitamins C and E) and Calcium Channel Blockers (nimodipine)
Trial: 11332356
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antioxidants or calcium channel blockers)
Trial: 8935814
Drug: Naturalistic discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturalistic discontinuation of clozapine in neuroleptic‐resistant patients
Trial: 30834652
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow rate reduction of 100 mL/min to a minimum of 300 mL/min
Trial: 29080069
Drug: 5-Aminosalicylic Acid
RxNorm normalized name: 5-aminosalicylic acid
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-Aminosalicylic Acid (5-ASA) 500 mg capsules, four times daily for 6 weeks
Trial: 27426231
Drug: LFCN block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LFCN block with 8 ml of 0.75% ropivacaine
Trial: 27426231
Drug: LFCN block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LFCN block with 8 ml of saline
Trial: 22824201
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg everolimus daily
Trial: 22824201
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg everolimus daily
Trial: 8205252
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of lipiodol (0.5 ml) 1-3 months before conception (Group A)
Trial: 8205252
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of lipiodol (0.5 ml) during the first month of pregnancy (Group B)
Trial: 8205252
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of lipiodol (0.5 ml) during the third month of pregnancy (Group C)
Trial: 11139949
Drug: Amiodarone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (200 mg/day)
Trial: 2252196
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% hydrocortisone cream
Trial: 1090905
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy sessions led by two nurses, twice a week for 20 sessions
Trial: 28229515
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy sessions
Trial: 31801563
Drug: Single orally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single orally administered dose of azithromycin
Trial: 23025390
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of yellow mustard bran
Trial: 20932157
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with GaAlAs diode laser, 808 nm wavelength, energy density of 4 J/cm² applied on days 1, 2, and 7 after periodontal treatment
Trial: 20932157
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (non-surgical periodontal therapy without LLLT)
Trial: 16926245
Drug: Testosterone (T)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (T) gel therapy, 50 mg/d for 6 months
Trial: 15624399
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment of varicocele
Trial: 11701677
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone patch plus oral desogestrel (300 microg/d)
Trial: 11701677
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone patch plus oral desogestrel (150 microg/d)
Trial: 11701677
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone patch plus oral desogestrel (75 microg/d)
Trial: 11701677
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone patch plus oral desogestrel (various doses)
Trial: 9385486
Drug: Ciprofloxacin (CIP)
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (CIP) 750 mg BID for 10 days
Trial: 9385486
Drug: Clarithromycin (CLR)
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin (CLR) 500 mg BID for 10 days
Trial: 3034221
Drug: oral metyrapone
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral metyrapone tartrate
Trial: 28646216
Drug: Naftopidil 75
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 75 mg once daily
Trial: 23208521
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine (0.125%) with fentanyl (2 µg/ml)
Trial: 19568711
Drug: Artequick (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artequick (administered twice in 24 h)
Trial: 19568711
Drug: Artekin (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artekin (administered 4 times in 2 days)
Trial: 11882452
Drug: Transmyocardial revascularization
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TRANSENDOCARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmyocardial revascularization with CO(2) laser in addition to medical treatment
Trial: 11882452
Drug: Continued optimal
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued optimal medical treatment
Trial: 9089559
Drug: Estradiol-releasing vaginal
RxNorm normalized name: estradiol Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol-releasing vaginal ring with a 100 mg vaginal progesterone suppository (7 days every month)
Trial: 9089559
Drug: Transdermal daily
RxNorm normalized name: PATCH, TRANSDERMAL DAILY, SEQUENTIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal daily dose of 50 micrograms of estradiol with a levonorgestrel-releasing intrauterine device
Trial: 3131040
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 100 mg recombinant tissue-type plasminogen activator (rt-PA) over 3 hours
Trial: 31277796
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept 2 mg every 4 weeks
Trial: 28007457
Drug: Vascular-targeted photodynamic
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vascular-targeted photodynamic therapy (4 mg/kg padeliporfin intravenously over 10 min, laser activation for 22 min 15 s)
Trial: 28007457
Drug: Vascular-targeted photodynamic
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vascular-targeted photodynamic therapy
Trial: 2857901
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of 100 micrograms human alpha‐ANP
Trial: 21544074
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen 1,000 mg
Trial: 17288697
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin (HIIP; AIR inhaled insulin)
Trial: 17288697
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin (regular human insulin or insulin lispro)
Trial: 15337620
Drug: Standard aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard aspirin and dipyridamole treatment b.i.d. for 2 weeks
Trial: 15337620
Drug: Titration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration with aspirin only in the morning and aspirin and dipyridamole in the evening for 5 days, followed by 9 days of standard aspirin and dipyridamole treatment
Trial: 19419595
Drug: Haloperidol (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (5-20 mg/d)
Trial: 1894296
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg intravenous oxyfedrine
Trial: 10500058
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg once daily)
Trial: 30198872
Drug: Naproxen (220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (220 mg twice-daily)
Trial: 22260859
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of fish oil (1.1 g marine n‐3 PUFA)
Trial: 22260859
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of olive oil (control)
Trial: 12038948
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of cevimeline 3 times daily
Trial: 11920411
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of cevimeline 3 times daily
Trial: 9823079
Drug: Oscillating/rotating power
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oscillating/rotating power toothbrush (Braun Oral‐B Ultra Plaque Remover‐D9)
Trial: 7967427
Drug: 12 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 Gy fractionated total body irradiation (FTBI) and 2 (or 3) cytotoxic drugs (group A, n = 19)
Trial: 7967427
Drug: 3 cytotoxic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 cytotoxic drugs (group B, n = 9)
Trial: 15204150
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (TCS)
Trial: 25070546
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel (wPxl; 80 mg/m(2)/week ×6 with 2‐week break) plus saracatinib (S; 175 mg o.d.)
Trial: 25070546
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel (wPxl; 80 mg/m(2)/week ×6 with 2‐week break) plus placebo (P)
Trial: 23347605
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100mg daily for 5 days
Trial: 23347605
Drug: Cimicifuga racimosa
RxNorm normalized name: Cimicifuga racemosa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimicifuga racimosa 20mg daily for 10 days
Trial: 17440520
Drug: Probiotic yoghurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yoghurt supplement containing L. acidophilus 74-2 and B. lactis 420 (300 g/day)
Trial: 17242812
Drug: Dopaminergic agents,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic agents, anticonvulsants, opioids, benzodiazepines, zolpidem, entacapone, ketamine
Trial: 17242812
Drug: Gabapentin and
RxNorm normalized name: Gabapentin and mecobalamin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin and L-dopa (sustained release formulation)
Trial: 12527491
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream vs Placebo
Trial: 10212103
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (500 microg twice daily) for four weeks
Trial: 8729126
Drug: steroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: steroids and other immunosuppressive agents (e.g., cyclosporin A)
Trial: 25066554
Drug: Non-vitamin K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-vitamin K oral anticoagulants (NOACs)
Trial: 27346176
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose edoxaban
Trial: 27346176
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose edoxaban
Trial: 24618935
Drug: Empiric antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric antibiotic therapy in FN episodes with bacteremia
Trial: 20549832
Drug: everolimus 10
RxNorm normalized name: everolimus 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: everolimus 10 mg/d
Trial: 12410482
Drug: Switching from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching from protease inhibitors to alternative drugs
Trial: 12410482
Drug: Switching thymidine
RxNorm normalized name: Thymidine
DrugBank: Thymidine (DB04485)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching thymidine analogue reverse-transcriptase inhibitors
Trial: 12410482
Drug: Substitution of
RxNorm normalized name: hydroxypropyl cellulose, low substituted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substitution of other agents for protease inhibitors
Trial: 10190874
Drug: Testosterone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (2.5 mg IV in 5 minutes)
Trial: 30168611
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) mediated by methylene blue and red laser diode (Periowave®, λ = 670 nm, 200 mW)
Trial: 21115098
Drug: Sandblasting with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandblasting with aluminium oxide particles followed by silane coupling agent
Trial: 21115098
Drug: Immersion in
RxNorm normalized name: OCTOCRYLENE 10 g in 100 g / HOMOSALATE 10 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Eucerin Face immersive Hydration]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immersion in 9.6% hydrofluoric acid gel for 60 s and silanization for 60 s
Trial: 21115098
Drug: No surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No surface treatment (Control)
Trial: 18046883
Drug: Alpha-1-blockers (A1Bs)
RxNorm normalized name: alpha 1-antitrypsin
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-1-blockers (A1Bs)